Oregon 2025 Regular Session

Oregon House Bill HB3211

Introduced
1/13/25  
Refer
1/17/25  
Report Pass
4/7/25  
Engrossed
4/15/25  

Caption

Relating to health directives.

Impact

The bill is significant in reshaping how patient preferences regarding pain management are documented and respected within healthcare settings. By establishing a formal directive mechanism, it aims to empower patients in their care decisions while also paving the way for clearer guidelines on opioid administration. The directive form includes critical warnings about the potential risks of opting out of opioids, such as unrelieved pain, which ensures that patients understand the implications of their choice.

Summary

House Bill 3211 requires the Oregon Health Authority (OHA) to develop and make available a nonopioid directive form that patients can use to specify their preferences regarding the administration of opioids. This form allows individuals—or their representatives—to formally express that they do not wish to receive opioids except under certain conditions. Healthcare providers must then incorporate this directive into the patient's medical records, promoting better patient autonomy in managing pain relief options.

Sentiment

The overall sentiment surrounding HB 3211 appears to be supportive, particularly from advocates for patient rights and those concerned about opioid over-prescription. Proponents see it as a vital step towards giving patients more control over their treatment options amid the ongoing opioid crisis. However, there are cautions about the balance required in ensuring that patients are adequately informed about the risks associated with foregoing opioid treatment, indicating a need for careful communication and support from healthcare providers.

Contention

While the bill fosters patient autonomy, it also raises concerns regarding the potential for unrelieved pain and the complexities of managing situations where opioid treatment may become necessary despite a patient's directive. Healthcare professionals may face ethical dilemmas in adhering to the directive amidst emergency scenarios or when treating conditions that could warrant opioid use, highlighting the challenges in balancing patient wishes, medical ethics, and appropriate pain management.

Companion Bills

No companion bills found.

Similar Bills

MD HB737

Public Health - Nonopioid Advance Directives

TX HB2085

Relating to general procedures and requirements for a nonopioid directive.

MN SF1814

Nonopioid directives usage authorization provision and certain acts of failure to act immunity establishment provision

MN HF1379

Use of nonopioid directives authorized, and immunity for certain acts or failures to act established.

CA ACR17

National Certified Registered Nurse Anesthetists Week.

NJ A4682

Prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs.

IL HB2852

NONOPIOID ALTERNATIVES ACT

IL SB1238

NONOPIOID ALTERNATIVES